WallStreetZenWallStreetZen

NASDAQ: ALLR
Allarity Therapeutics Inc Stock Ownership - Who owns Allarity Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Allarity Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jeremy R. GraffPresident and Chief Development Officer2024-09-30118,483$2.11
$250.00kBuy

1 of 1

ALLR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALLR insiders and whales buy or sell their stock.

ALLR Shareholders

What type of owners hold Allarity Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Leon Sass6.38%1,086,238$1.24MInsider
Thomas Jensen2.33%396,734$452.28kInsider
Jeremy R. Graff1.55%262,924$299.73kInsider
Steen Knudsen0.73%124,976$142.47kInsider
Alexander Epshinsky0.50%85,051$96.96kInsider
Stonepine Capital Management LLC0.40%67,289$76.71kInstitution
Duncan Moore0.13%22,672$25.85kInsider
Goldman Sachs Group Inc0.12%20,616$23.50kInstitution
Citigroup Inc0.07%12,294$14.02kInstitution
Tower Research Capital LLC Trc0.03%4,266$4.86kInstitution

1 of 2

ALLR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALLR0.61%11.67%Net Buying
LSTA0.89%99.11%Net Selling
LEXX8.21%3.91%Net Buying
PMN29.82%28.65%Net BuyingNet Buying
PASG44.81%55.19%Net SellingNet Selling
View Top Biotech Stocks

Allarity Therapeutics Stock Ownership FAQ

Who owns Allarity Therapeutics?

Allarity Therapeutics (NASDAQ: ALLR) is owned by 0.61% institutional shareholders, 11.67% Allarity Therapeutics insiders, and 87.72% retail investors. Leon Sass is the largest individual Allarity Therapeutics shareholder, owning 1.09M shares representing 6.38% of the company. Leon Sass's Allarity Therapeutics shares are currently valued at $1.30M.

If you're new to stock investing, here's how to buy Allarity Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.